Monday, July 24, 2023 Daily Archives

Sartorius: ‘Normalization’ continues, analysts eye 2024 for recovery

by

Bioprocessing continues to ‘muddle along’ through a prolonged post-COVID comedown but Sartorius should see a return to normal sales and ordering patterns in the coming quarters. Sartorius Stedim Biotech reported sales of €1.140 billion ($1.26 billion) in the first half 2023, down 18.7% on the same period last year. Order intake, meanwhile, fell 37.5% to €1.142 billion. The company attributed this to the continued decline in demand for bioprocess technologies and services following two years of unprecedented growth during the…

July 24, 2023

Biopharma calls on vendors to commit to ‘greener’ supply chain

by

CEOs from Roche, GSK, and AstraZeneca are among signatories of an open letter calling on suppliers to commit to climate and sustainability targets. The healthcare sector contributes around 5% of global greenhouse gas emissions, half of which comes from supply chains, the letter claims before calling on biopharma partners to rapidly move towards a “greener, more efficient, and circular” process. The letter – also signed by the CEOs of Big Pharma firms Novo Nordisk, Merck KGaA, and Sanofi, as well…

July 24, 2023

MIT receives $82m from FDA for continuous mRNA manufacturing platform

by

With $82 million in FDA funding, MIT will conduct a three-year research program to design a fully integrated continuous mRNA platform. The Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA) will distribute the funds to Massachusetts Institute of Technology (MIT) over a three-year period. A significant portion of the program has been subcontracted to ReciBioPham (previously Arranta Bio), which partnered with MIT in May to develop a continuous manufacturing technology for messenger RNA (mRNA)…

July 24, 2023